Taumedis

What Taumedis does

Taumedis is a Canadian medical technology company founded in 2018 and headquartered in Winnipeg, Manitoba. The company develops intraoperative imaging systems, with its core offering being a floor-moving, high-field 1.5T intraoperative MRI (iMRI) system that uses a proprietary ground-based Magnet Transport System (MTS) to bring the MRI scanner to the patient in the operating room rather than moving the patient. The system targets hospitals and neurosurgical programs seeking real-time MR imaging during brain surgery without patient transfer. Taumedis also lists Intraoperative PET (iPET) and Intraoperative Ultrasound (iUS) as part of its technology platform, and is developing Dual-Mode Imaging technology that combines ultrasound and microwave imaging for breast cancer screening, in partnership with the University of Manitoba's Electromagnetic Imaging Laboratory.

The iMRI system is built around multiple proprietary components: a cryogen-free 1.5T MRI with AI-powered image reconstruction and noise reduction, an MR-compatible neurosurgical OR table, a flexible 8-channel RF coil compatible with Mayfield-style fixation, a Patient Imaging Positioning System (PIPS) using projected laser crosshair positioning, and RF/magnetic shielding with pneumatic-seal doors. The Magnet Transport System is a tracked crawler designed to mobilize up to five tons with sub-millimeter positioning accuracy, anti-collision detection, and less than three-minute transit time between an adjacent Diagnostic Room or Magnet Storage Bay and the Operating Room. The company cites its team's prior role in co-designing and installing the first FDA-cleared clinical iMRI at Boston Children's Hospital in 2004 as evidence of execution capability.

Taumedis is currently pre-revenue, with all products under development and not yet authorized for sale by the FDA or Health Canada. The intended business model is direct enterprise sales of capital imaging equipment to hospitals, supplemented by professional services for implementation, workflow optimization, and staff training. Pricing is custom and not publicly disclosed. In June 2026, the company achieved ISO 13485:2016 and MDSAP certification through Intertek, establishing a multi-market quality management foundation. The company has no disclosed funding rounds, no identified institutional investors, and operates with 1-10 employees while maintaining an active investor relations portal indicating ongoing capital needs.

Name

Taumedis

Legal name

Taumedis Inc.

Website

https://taumedis.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

1–10 employees

Short description

Taumedis is a Canadian medical technology company developing a floor-moving, high-field 1.5T intraoperative MRI system with a proprietary Magnet Transport System, plus Dual-Mode ultrasound-microwave imaging for breast cancer screening, targeting hospitals and neurosurgical programs.

Ownership category

akta.pro rank

Product category

Intraoperative Medical Imaging Equipment

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Medical Equipment and Supplies Manufacturing (3391)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence) (HLAHADAH)

akta.pro secondary industries

Magnetic Resonance Imaging (MRI) Systems (HLAHABAC), Medical Imaging AI (HDAAAEAH)

Keywords

• Intraoperative MRI systems
• Medical imaging devices
• Neurosurgical imaging equipment
• Breast cancer imaging
• Diagnostic imaging hardware

Headquarters

HQ city

Winnipeg

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

1. Intraoperative MRI Systems: Sale of iMRI systems to hospitals and neurosurgical programs. The company is developing the system with plans for FDA commercial licensing followed by sales and marketing. Hospital acquisition costs include system, construction, shielding, room design, MR-compatible equipment, and service.
2. Dual-Mode Imaging Technology: Commercialization of dual-mode imaging technology for breast cancer screening following successful human studies and regulatory approvals.
3. Professional Services: Clinical specialist support for iMRI implementation, workflow optimization, and staff training consistent with local policies and procedures.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Core offering

Taumedis develops and intends to commercialize intraoperative and diagnostic medical imaging hardware, anchored by the Intraoperative MRI (iMRI) System — a floor-moving, high-field 1.5T MRI with a proprietary Magnet Transport System that brings the scanner to the patient during neurosurgery. The portfolio also includes Intraoperative PET (iPET), Intraoperative Ultrasound (iUS), and a Dual-Mode Imaging system combining ultrasound and microwave for breast cancer screening. All products are currently under development and not yet authorized for sale.

Product overview

Taumedis is a Canadian medical technology company developing a multi-modality imaging portfolio. The core offering includes the Intraoperative MRI (iMRI) System - the world's first floor-moving, high-field 1.5T iMRI solution featuring a proprietary Magnet Transport System (MTS) that brings the MRI scanner to the patient in the OR without moving the patient. This system includes sub-components: MR-compatible neurosurgical table, cranial stabilization system, flexible 8-channel RF coil, and Patient Imaging Positioning System (PIPS). The company also develops Intraoperative PET (iPET) and Intraoperative Ultrasound (iUS) for real-time surgical support. Additionally, Taumedis is developing Dual-Mode Imaging technology in partnership with the University of Manitoba, combining ultrasound and microwave imaging for breast cancer screening workflows. All iMRI products are currently under development and not yet authorized for sale.

Differentiator

Problem solved

Functional benefit

Products and services

• Intraoperative MRI (iMRI) System Floor-moving, high-field 1.5T intraoperative MRI solution featuring a ground-based Magnet Transport System (MTS) that mobilizes the MRI between an adjacent Diagnostic Room or Magnet Storage Bay and the Operating Room while the patient remains stable. Includes MR-compatible neurosurgical table, Mayfield-style cranial stabilization, flexible 8-channel RF coil, RF/H shielding, and AI-powered image reconstruction. Aimed at hospitals with neurosurgical programs for real-time intraoperative MRI during neurosurgery.
• Magnet Transport System (MTS) Ground-based tracked crawler system that mobilizes the 1.5T MRI scanner between Diagnostic Room or Magnet Storage Bay and the Operating Room. Designed for less than 3-minute transit time, sub-millimeter positioning accuracy, anti-collision detection, safety interlock, and supports up to 5 tons while distributing magnet load over the entire track area.
• MR-Compatible Neurosurgical OR Table MR-compatible neurosurgical operating room table designed for intraoperative imaging with multi-axis adjustment including horizontal deck movement up to 200mm. The table can be removed from the OR to accommodate different procedures.
• MR-Compatible Cranial Stabilization System MR-compatible, radiolucent Mayfield-style skull clamp providing rigid cranial fixation during surgery and imaging. Supports prone, supine, and lateral positioning for neurosurgical cases performed under intraoperative MRI.
• Flexible 8-Channel Neurosurgical RF Coil 8-channel, two-piece flexible design with anterior/posterior arrays (four channels each) compatible with Mayfield-style fixation devices. Provides imaging coverage for the brain and upper cervical spine (to C3) during intraoperative scans.
• Patient Imaging Positioning System (PIPS) Projected laser crosshair reference system placed at the region of interest to align magnet isocenter positioning and guide imaging accuracy and workflow during intraoperative MRI.
• Intraoperative PET (iPET) Positron Emission Tomography (PET) imaging technology integrated directly into the operating room for real-time surgical support during procedures.
• Intraoperative Ultrasound (iUS) Ultrasound imaging technology integrated directly into the operating room for real-time intraoperative imaging during surgical procedures.
• Dual-Mode Imaging Technology Dual-mode breast cancer imaging system combining ultrasound and microwave imaging into a single device, designed to work alongside existing screening tools such as mammograms. Intended for breast cancer screening, diagnosis support, and monitoring of treatment effectiveness.

Quantifiable outcome

• Published neurosurgical studies associate iMRI with improved extent of resection in selected brain tumor procedures
• +3 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature6 records

Partnerships

One partnership is on record.

• University of Manitoba - Electromagnetic Imaging Laboratory (EIL)coreStrategic or Co-development Partner · 28 April 2026Taumedis partnered with University of Manitoba researchers in the Price Faculty of Engineering to develop Dual-Mode Imaging technology combining ultrasound and microwave imaging for breast cancer screening and diagnosis. The partnership involves UM's Electromagnetic Imaging Laboratory led by Joe LoVetri. First-in-Human study planned for 2026 pending regulatory and ethics approvals. The collaboration aims to advance imaging technologies for improved clinical assessment and patient outcomes.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• IMRIS: IMRIS is the established leader in intraoperative MRI and a former employer of two Taumedis co-founders; it sells ceiling- and floor-mounted iMRI suites to neurosurgical programs, making it the closest direct competitor to Taumedis' iMRI system.
• Brainlab: Brainlab specializes in image-guided surgery, surgical navigation, and intraoperative imaging software; it is a direct peer in the neurosurgical OR imaging workflow where Taumedis' iMRI and navigation-adjacent technologies compete and integrate.

Broad incumbents

• Medtronic: Medtronic's neurosurgery and surgical navigation businesses (StealthStation, O-arm) compete with intraoperative imaging-enabled workflows and represent a scaled incumbent Taumedis must position against for neurosurgical capital budget.
• Hologic: Hologic is a leading women's health imaging vendor (3Dimensions mammography, ultrasound) and would be the incumbent screening-equipment vendor competing for the breast imaging capital budget Taumedis' dual-mode technology targets.
• Siemens Healthineers: Siemens is a dominant MRI manufacturer (MAGNETOM family) and broader medical imaging incumbent; its high-field MRI platforms and OR-integrated solutions represent the large incumbent alternative against which Taumedis must compete on performance and price.
• Philips Healthcare: Philips is a leading MRI and image-guided therapy vendor (Ingenia, Azurion) with deep neurosurgery and oncology channel reach; it overlaps with Taumedis on intraoperative imaging workflows and AI-enabled reconstruction.
• GE HealthCare: GE HealthCare offers the SIGNA MRI portfolio and broad hospital imaging solutions; it competes with Taumedis in high-field MRI hardware, AI image reconstruction, and integrated surgical-suite imaging for neurosurgery programs.
• Stryker: Stryker's surgical navigation, cranial fixation (e.g., Mayfield — referenced in Taumedis' RF coil compatibility), and neurosurgical capital equipment portfolios overlap with Taumedis' intraoperative neurosurgery offering.

Emerging players

• Seno Medical Instruments: Seno Medical develops opto-acoustic/ultrasound-based breast imaging as a complement to mammography; it is comparable to Taumedis' Dual-Mode Imaging business as a novel, non-ionizing breast cancer screening modality.
• Delphinus Medical Technologies: Delphinus offers SoftVue, an ultrasound-based breast tomography system for dense breast screening; it competes in the same novel, non-mammogram adjunctive breast imaging category as Taumedis' ultrasound+microwave dual-mode platform.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/watch?v=pjEFQaJqc3M
• LinkedInlinkedin.com/company/company
• Xx.com/Taumedis
• Facebookfacebook.com/taumedis

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Taumedis